vs
Side-by-side financial comparison of Cintas (CTAS) and Organon & Co. (OGN). Click either name above to swap in a different company.
Cintas is the larger business by last-quarter revenue ($2.8B vs $1.5B, roughly 1.9× Organon & Co.). Cintas runs the higher net margin — 17.7% vs -13.6%, a 31.3% gap on every dollar of revenue. On growth, Cintas posted the faster year-over-year revenue change (9.3% vs -5.3%). Cintas produced more free cash flow last quarter ($425.0M vs $96.0M). Over the past eight quarters, Cintas's revenue compounded faster (7.9% CAGR vs -3.6%).
Cintas Corporation is an American corporation headquartered in Mason, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses. Cintas is a publicly held company traded on the Nasdaq Global Select Market under the symbol CTAS and is a component of the S&P 500 Index.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
CTAS vs OGN — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8B | $1.5B |
| Net Profit | $495.3M | $-205.0M |
| Gross Margin | 50.4% | 49.2% |
| Operating Margin | 23.4% | -9.8% |
| Net Margin | 17.7% | -13.6% |
| Revenue YoY | 9.3% | -5.3% |
| Net Profit YoY | 10.4% | -288.1% |
| EPS (diluted) | $1.21 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8B | $1.5B | ||
| Q3 25 | $2.7B | $1.6B | ||
| Q2 25 | $2.7B | $1.6B | ||
| Q1 25 | $2.6B | $1.5B | ||
| Q4 24 | $2.6B | $1.6B | ||
| Q3 24 | $2.5B | $1.6B | ||
| Q2 24 | $2.5B | $1.6B | ||
| Q1 24 | $2.4B | $1.6B |
| Q4 25 | $495.3M | $-205.0M | ||
| Q3 25 | $491.1M | $160.0M | ||
| Q2 25 | $448.3M | $145.0M | ||
| Q1 25 | $463.5M | $87.0M | ||
| Q4 24 | $448.5M | $109.0M | ||
| Q3 24 | $452.0M | $359.0M | ||
| Q2 24 | $414.3M | $195.0M | ||
| Q1 24 | $397.6M | $201.0M |
| Q4 25 | 50.4% | 49.2% | ||
| Q3 25 | 50.3% | 53.5% | ||
| Q2 25 | 49.7% | 54.8% | ||
| Q1 25 | 50.6% | 55.6% | ||
| Q4 24 | 49.8% | 56.3% | ||
| Q3 24 | 50.1% | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 23.4% | -9.8% | ||
| Q3 25 | 22.7% | 15.2% | ||
| Q2 25 | 22.4% | 14.4% | ||
| Q1 25 | 23.4% | 6.7% | ||
| Q4 24 | 23.1% | 8.1% | ||
| Q3 24 | 22.4% | 13.1% | ||
| Q2 24 | 22.2% | 14.6% | ||
| Q1 24 | 21.6% | 14.5% |
| Q4 25 | 17.7% | -13.6% | ||
| Q3 25 | 18.1% | 10.0% | ||
| Q2 25 | 16.8% | 9.1% | ||
| Q1 25 | 17.8% | 5.8% | ||
| Q4 24 | 17.5% | 6.8% | ||
| Q3 24 | 18.1% | 22.7% | ||
| Q2 24 | 16.8% | 12.1% | ||
| Q1 24 | 16.5% | 12.4% |
| Q4 25 | $1.21 | $-0.78 | ||
| Q3 25 | $1.20 | $0.61 | ||
| Q2 25 | $1.08 | $0.56 | ||
| Q1 25 | $1.13 | $0.33 | ||
| Q4 24 | $1.09 | $0.42 | ||
| Q3 24 | $1.10 | $1.38 | ||
| Q2 24 | $4.00 | $0.75 | ||
| Q1 24 | $3.84 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $200.8M | $574.0M |
| Total DebtLower is stronger | $2.4B | $8.6B |
| Stockholders' EquityBook value | $4.5B | $752.0M |
| Total Assets | $10.1B | $12.9B |
| Debt / EquityLower = less leverage | 0.54× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $200.8M | $574.0M | ||
| Q3 25 | $138.1M | $672.0M | ||
| Q2 25 | $264.0M | $599.0M | ||
| Q1 25 | $243.4M | $547.0M | ||
| Q4 24 | $122.4M | $675.0M | ||
| Q3 24 | $101.4M | $763.0M | ||
| Q2 24 | $342.0M | $704.0M | ||
| Q1 24 | $128.5M | $575.0M |
| Q4 25 | $2.4B | $8.6B | ||
| Q3 25 | $2.4B | $8.8B | ||
| Q2 25 | $2.4B | $8.9B | ||
| Q1 25 | $2.0B | $9.0B | ||
| Q4 24 | $2.0B | $8.9B | ||
| Q3 24 | $2.0B | $8.7B | ||
| Q2 24 | $2.0B | $8.7B | ||
| Q1 24 | $2.5B | $8.7B |
| Q4 25 | $4.5B | $752.0M | ||
| Q3 25 | $4.8B | $906.0M | ||
| Q2 25 | $4.7B | $733.0M | ||
| Q1 25 | $4.6B | $542.0M | ||
| Q4 24 | $4.3B | $472.0M | ||
| Q3 24 | $4.0B | $493.0M | ||
| Q2 24 | $4.3B | $144.0M | ||
| Q1 24 | $4.2B | $48.0M |
| Q4 25 | $10.1B | $12.9B | ||
| Q3 25 | $9.8B | $13.6B | ||
| Q2 25 | $9.8B | $13.5B | ||
| Q1 25 | $9.6B | $13.2B | ||
| Q4 24 | $9.4B | $13.1B | ||
| Q3 24 | $9.1B | $12.8B | ||
| Q2 24 | $9.2B | $12.2B | ||
| Q1 24 | $9.0B | $11.9B |
| Q4 25 | 0.54× | 11.49× | ||
| Q3 25 | 0.51× | 9.74× | ||
| Q2 25 | 0.52× | 12.14× | ||
| Q1 25 | 0.44× | 16.52× | ||
| Q4 24 | 0.47× | 18.81× | ||
| Q3 24 | 0.50× | 17.75× | ||
| Q2 24 | 0.47× | 60.11× | ||
| Q1 24 | 0.58× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $531.2M | $141.0M |
| Free Cash FlowOCF − Capex | $425.0M | $96.0M |
| FCF MarginFCF / Revenue | 15.2% | 6.4% |
| Capex IntensityCapex / Revenue | 3.8% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.07× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.8B | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.2M | $141.0M | ||
| Q3 25 | $414.5M | $264.0M | ||
| Q2 25 | $635.7M | $220.0M | ||
| Q1 25 | $622.0M | $75.0M | ||
| Q4 24 | $441.4M | $390.0M | ||
| Q3 24 | $466.7M | $141.0M | ||
| Q2 24 | $693.0M | $332.0M | ||
| Q1 24 | $657.1M | $76.0M |
| Q4 25 | $425.0M | $96.0M | ||
| Q3 25 | $312.5M | $218.0M | ||
| Q2 25 | $521.1M | $181.0M | ||
| Q1 25 | $522.1M | $43.0M | ||
| Q4 24 | $340.0M | $335.0M | ||
| Q3 24 | $373.8M | $99.0M | ||
| Q2 24 | $591.1M | $300.0M | ||
| Q1 24 | $550.1M | $30.0M |
| Q4 25 | 15.2% | 6.4% | ||
| Q3 25 | 11.5% | 13.6% | ||
| Q2 25 | 19.5% | 11.4% | ||
| Q1 25 | 20.0% | 2.8% | ||
| Q4 24 | 13.3% | 21.0% | ||
| Q3 24 | 14.9% | 6.3% | ||
| Q2 24 | 23.9% | 18.7% | ||
| Q1 24 | 22.9% | 1.8% |
| Q4 25 | 3.8% | 3.0% | ||
| Q3 25 | 3.8% | 2.9% | ||
| Q2 25 | 4.3% | 2.4% | ||
| Q1 25 | 3.8% | 2.1% | ||
| Q4 24 | 4.0% | 3.5% | ||
| Q3 24 | 3.7% | 2.7% | ||
| Q2 24 | 4.1% | 2.0% | ||
| Q1 24 | 4.4% | 2.8% |
| Q4 25 | 1.07× | — | ||
| Q3 25 | 0.84× | 1.65× | ||
| Q2 25 | 1.42× | 1.52× | ||
| Q1 25 | 1.34× | 0.86× | ||
| Q4 24 | 0.98× | 3.58× | ||
| Q3 24 | 1.03× | 0.39× | ||
| Q2 24 | 1.67× | 1.70× | ||
| Q1 24 | 1.65× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTAS
| Uniform Rental And Facility Services Segment | $2.2B | 77% |
| First Aid And Safety Services Segment | $342.2M | 12% |
| Fire Protection Services | $222.5M | 8% |
| Uniform Direct Sales | $79.8M | 3% |
OGN
Segment breakdown not available.
